ClinicalTrials.Veeva

Menu

Invasive Pulmonary Aspergillosis and Severe Influenza (ASPERGIGRIPP)

R

Regional University Hospital Center (CHRU)

Status

Completed

Conditions

Influenza
Critical Illness
Aspergillosis

Study type

Observational

Funder types

Other

Identifiers

NCT04232956
ASPERGIGRIPP (29BRC18.0069)

Details and patient eligibility

About

Invasive pulmonary aspergillosis (IPA) has been reported in critically ill patients with influenza infection with a highly variable incidence between 1 to 21%. Studies investigating IPA in critically ill patients with influenza infection suffer limitations in their methods. It remains unknown whether patients with influenza are more at risk of IPA than other patients hospitalized in intensive care unit and whether patients with influenza who develop IPA have specific risk factors for this infection.

Our study aims to determine the incidence of IPA in a large multicenter cohort and to identify risk factors for IPA in these patients.

Enrollment

478 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Infection with influenza A or B
  • Admission to one of the participating sites

Exclusion criteria

  • age < 18
  • patients with invasive pulmonary aspergillosis prior to intensive care admission
  • consent withdraw

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems